HomeHealthIllumina to Host Upcoming Investor Day

Illumina to Host Upcoming Investor Day

Published on

<br /> Illumina to Host Upcoming Investor Day<br />

PR Newswire



SAN DIEGO


,


Sept. 19, 2022


/PRNewswire/ — Illumina, Inc. (Nasdaq: ILMN) will host its 2022 Investor Day on

Monday, October 3


rd

starting at

8:00am Pacific Time

in

San Diego, CA.

The event will feature presentations by members of Illumina’s executive team and conclude with a Q&A session.

A live webcast of the event can be accessed through the Investor Info section of Illumina’s website at

investor.illumina.com

. A replay will be posted on Illumina’s website after the event and will be available for at least 30 days following.



About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit

www.illumina.com

and connect with us on

Twitter

,

Facebook

,

LinkedIn

,

Instagram

, and

YouTube

.

Investors:


Salli Schwartz


+1.858.291.6421


[email protected]

Media:


Sarah Shew


+1.858.336.3157


[email protected]

Cision
View original content:

https://www.prnewswire.com/news-releases/illumina-to-host-upcoming-investor-day-301627519.html

SOURCE Illumina, Inc.

rt Illumina to Host Upcoming Investor Day

Featured image: © healthHFJO3

Disclaimer

Latest News

BD, CerTest Biotec Announce US Commercial Launch of Monkeypox Assay

BD, CerTest Biotec Announce US Commercial Launch of...

Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study

Creative Medical Technology Announces Peer Reviewed Publication of...

Centene Subsidiary Selected to Continue Serving Nebraska’s Medicaid Managed Care Members

Centene Subsidiary Selected to Continue Serving Nebraska's Medicaid...

More like this

Optimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada

Optimi (CSE:OPTI)(OTCQX:OPTHF)(FRA:8BN) aiming to become the first vertically integrated psychedelics firm to formulate and...

GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr

The exclusive license allows GSK to commercialize tebipenem HBr in...

iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline

– Positions Company for leadership in AI-powered drug discovery – ...

CVS Health reports progress against goal to reduce suicide attempts among Aetna members 20% by 2025

CVS Health reports progress against goal to reduce...